Trial Profile
A Pilot Study of Adcetris Treatment in Active Diffuse Cutaneous Systemic Sclerosis (Diffuse Scleroderma)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2023
Price :
$35
*
At a glance
- Drugs Brentuximab vedotin (Primary) ; Azathioprine; Cyclophosphamide; Methotrexate; Mycophenolate mofetil; Mycophenolic acid
- Indications Diffuse scleroderma
- Focus Therapeutic Use
- 03 Oct 2023 Status changed from active, no longer recruiting to completed.
- 07 Mar 2023 Planned End Date changed from 1 Feb 2023 to 1 Oct 2023.
- 07 Mar 2023 Planned primary completion date changed from 1 Oct 2022 to 1 Jul 2023.